140 related articles for article (PubMed ID: 21175447)
1. Erlotinib and pantoprazole: a relevant interaction or not?
Ter Heine R; Fanggiday JC; Lankheet NA; Beijnen JH; Van Der Westerlaken MM; Staaks GH; Malingré MM
Br J Clin Pharmacol; 2010 Dec; 70(6):908-11. PubMed ID: 21175447
[TBL] [Abstract][Full Text] [Related]
2. An evaluation of the possible interaction of gastric acid suppressing medication and the EGFR tyrosine kinase inhibitor erlotinib.
Hilton JF; Tu D; Seymour L; Shepherd FA; Bradbury PA
Lung Cancer; 2013 Oct; 82(1):136-42. PubMed ID: 23910908
[TBL] [Abstract][Full Text] [Related]
3. Effects of Proton Pump Inhibitor Coadministration on the Plasma Concentration of Erlotinib in Patients With Non-Small Cell Lung Cancer.
Ohgami M; Kaburagi T; Kurosawa A; Doki K; Shiozawa T; Hizawa N; Homma M
Ther Drug Monit; 2018 Dec; 40(6):699-704. PubMed ID: 29995672
[TBL] [Abstract][Full Text] [Related]
4. Population Pharmacokinetics of Erlotinib in Patients With Non-small Cell Lung Cancer: Its Application for Individualized Dosing Regimens in Older Patients.
Evelina Cardoso ; Guidi M; Khoudour N; Pascaline Boudou-Rouquette ; Fabre E; Tlemsani C; Arrondeau J; François Goldwasser ; Vidal M; Schneider MP; Wagner AD; Widmer N; Blanchet B; Csajka C
Clin Ther; 2020 Jul; 42(7):1302-1316. PubMed ID: 32631634
[TBL] [Abstract][Full Text] [Related]
5. Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.
van Leeuwen RW; Peric R; Hussaarts KG; Kienhuis E; IJzerman NS; de Bruijn P; van der Leest C; Codrington H; Kloover JS; van der Holt B; Aerts JG; van Gelder T; Mathijssen RH
J Clin Oncol; 2016 Apr; 34(12):1309-14. PubMed ID: 26858332
[TBL] [Abstract][Full Text] [Related]
6. Safety, pharmacokinetics, and pharmacodynamics of S-(-)-pantoprazole sodium injections after single and multiple intravenous doses in healthy Chinese subjects.
Jiao HW; Sun LN; Li YQ; Yu L; Zhang HW; Wang MF; Yu LY; Yuan ZQ; Xie LJ; Chen J; Meng L; Zhang XH; Wang YQ
Eur J Clin Pharmacol; 2018 Mar; 74(3):257-265. PubMed ID: 29167917
[TBL] [Abstract][Full Text] [Related]
7. Effects of pantoprazole on ulcer healing delay associated with NSAID treatment.
Fornai M; Colucci R; Antonioli L; Ghisu N; Tuccori M; Blandizzi C; Del Tacca M
Naunyn Schmiedebergs Arch Pharmacol; 2009 Mar; 379(3):305-13. PubMed ID: 18853145
[TBL] [Abstract][Full Text] [Related]
8. Pantoprazole: a proton pump inhibitor.
Moreira Dias L
Clin Drug Investig; 2009; 29 Suppl 2():3-12. PubMed ID: 19938880
[TBL] [Abstract][Full Text] [Related]
9. Pantoprazole: a proton pump inhibitor with oral and intravenous formulations.
Devault KR
Expert Rev Gastroenterol Hepatol; 2007 Dec; 1(2):197-205. PubMed ID: 19072410
[TBL] [Abstract][Full Text] [Related]
10. Pantoprazole available without a prescription: new status. Better than H2 receptor agonists, but not for pregnant women.
Prescrire Int; 2009 Dec; 18(104):250. PubMed ID: 20025090
[TBL] [Abstract][Full Text] [Related]
11. Comparison of omeprazole and pantoprazole influence on a high 150-mg clopidogrel maintenance dose the PACA (Proton Pump Inhibitors And Clopidogrel Association) prospective randomized study.
Cuisset T; Frere C; Quilici J; Poyet R; Gaborit B; Bali L; Brissy O; Morange PE; Alessi MC; Bonnet JL
J Am Coll Cardiol; 2009 Sep; 54(13):1149-53. PubMed ID: 19761935
[TBL] [Abstract][Full Text] [Related]
12. Effect of proton pump inhibitor pantoprazole on growth and morphology of oral Lactobacillus strains.
Altman KW; Chhaya V; Hammer ND; Pavlova S; Vesper BJ; Tao L; Radosevich JA
Laryngoscope; 2008 Apr; 118(4):599-604. PubMed ID: 18176340
[TBL] [Abstract][Full Text] [Related]
13. Single-dose, multiple-dose, and population pharmacokinetics of pantoprazole in neonates and preterm infants with a clinical diagnosis of gastroesophageal reflux disease (GERD).
Ward RM; Tammara B; Sullivan SE; Stewart DL; Rath N; Meng X; Maguire MK; Comer GM
Eur J Clin Pharmacol; 2010 Jun; 66(6):555-61. PubMed ID: 20306184
[TBL] [Abstract][Full Text] [Related]
14. EGFR kinase inhibitors and gastric acid suppressants in EGFR-mutant NSCLC: a retrospective database analysis of potential drug interaction.
Kumarakulasinghe NB; Syn N; Soon YY; Asmat A; Zheng H; Loy EY; Pang B; Soo RA
Oncotarget; 2016 Dec; 7(51):85542-85550. PubMed ID: 27907909
[TBL] [Abstract][Full Text] [Related]
15. Effect of gastric pH on erlotinib pharmacokinetics in healthy individuals: omeprazole and ranitidine.
Kletzl H; Giraudon M; Ducray PS; Abt M; Hamilton M; Lum BL
Anticancer Drugs; 2015 Jun; 26(5):565-72. PubMed ID: 25643050
[TBL] [Abstract][Full Text] [Related]
16. Dose-dependent control of intragastric pH by pantoprazole, 10, 20 or 40 mg, in healthy volunteers.
Tutuian R; Katz PO; Bochenek W; Castell DO
Aliment Pharmacol Ther; 2002 Apr; 16(4):829-36. PubMed ID: 11929403
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics, metabolism and interactions of acid pump inhibitors. Focus on omeprazole, lansoprazole and pantoprazole.
Andersson T
Clin Pharmacokinet; 1996 Jul; 31(1):9-28. PubMed ID: 8827397
[TBL] [Abstract][Full Text] [Related]
18. Negative inotropy of the gastric proton pump inhibitor pantoprazole in myocardium from humans and rabbits: evaluation of mechanisms.
Schillinger W; Teucher N; Sossalla S; Kettlewell S; Werner C; Raddatz D; Elgner A; Tenderich G; Pieske B; Ramadori G; Schöndube FA; Kögler H; Kockskämper J; Maier LS; Schwörer H; Smith GL; Hasenfuss G
Circulation; 2007 Jul; 116(1):57-66. PubMed ID: 17576869
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of omeprazole and pantoprazole on the pharmacodynamics and pharmacokinetics of clopidogrel in healthy subjects: randomized, placebo-controlled, crossover comparison studies.
Angiolillo DJ; Gibson CM; Cheng S; Ollier C; Nicolas O; Bergougnan L; Perrin L; LaCreta FP; Hurbin F; Dubar M
Clin Pharmacol Ther; 2011 Jan; 89(1):65-74. PubMed ID: 20844485
[TBL] [Abstract][Full Text] [Related]
20. Randomised clinical trial: twice daily esomeprazole 40 mg vs. pantoprazole 40 mg in Barrett's oesophagus for 1 year.
de Bortoli N; Martinucci I; Piaggi P; Maltinti S; Bianchi G; Ciancia E; Gambaccini D; Lenzi F; Costa F; Leonardi G; Ricchiuti A; Mumolo MG; Bellini M; Blandizzi C; Marchi S
Aliment Pharmacol Ther; 2011 May; 33(9):1019-27. PubMed ID: 21385192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
